Maurer H, Pfleger K
Institut für Pharmakologie und Toxikologie der Universität des Saarlandes, Homburg/Saar, F.R.G.
J Chromatogr. 1988 Aug 19;430(1):31-41. doi: 10.1016/s0378-4347(00)83131-x.
A gas chromatographic-mass spectrometric screening procedure is described for the identification and differentiation of the following alkylamine antihistamines and their metabolites in urine: azatadine, benzquinamide, brompheniramine, chlorphenamine, (clofedanol), cyproheptadine, dimetindene, ketotifen, mebhydroline, phenindamine, pheniramine, pyrrobutamine, terfenadine and tolpropamine. After acid hydrolysis of the conjugates, extraction and acetylation, the urine samples were analysed by computerized gas chromatography-mass spectrometry. Using ion chromatography with the selective ions m/z 58, 169, 203, 205, 230, 233, 262 and 337, the presence of alkylamine antihistamines and/or their metabolites was indicated. The identity of positive signals in the reconstructed ion chromatograms was confirmed by a visual or computerized comparison of the stored full mass spectra with the reference spectra. The ion chromatograms, reference mass spectra and gas chromatographic retention indices (OV-101) are documented. The procedure presented is integrated in a general screening procedure (general unknown analysis) for several groups of drugs.
描述了一种气相色谱 - 质谱筛选程序,用于鉴定和区分尿液中的以下烷基胺类抗组胺药及其代谢物:阿扎他定、苄喹酰胺、溴苯那敏、氯苯那敏、(氯苯达诺)、赛庚啶、二甲茚定、酮替芬、美吡拉敏、非尼拉敏、吡咯布他明、特非那定和托普帕敏。对结合物进行酸水解、萃取和乙酰化后,通过计算机化气相色谱 - 质谱对尿液样本进行分析。使用离子色谱,选择离子m/z 58、169、203、205、230、233、262和337,表明存在烷基胺类抗组胺药和/或其代谢物。通过将存储的全质谱与参考光谱进行目视或计算机化比较,确认重建离子色谱图中阳性信号的身份。记录了离子色谱图、参考质谱和气相色谱保留指数(OV - 101)。所介绍的程序集成在针对几类药物的一般筛选程序(一般未知物分析)中。